ArticleFrontiers in endocrinology2025
Factors influencing oocyte yield and embryo quality in donor IVF cycles: a retrospective cohort study.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Investigating discrepancies in accuracy, agreement and interpretability for single-frame embryo classification tasks conducted by embryologists and deep learning models.Frontiers in reproductive health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Achieving an optimal balance between oocyte yield and embryo quality is central to donor IVF. Although anti-Müllerian hormone (AMH) predicts oocyte quantity, donor characteristics and stimulation parameters may influence embryo developmental competence. We aimed to identify clinical and protocol-related factors associated with oocyte yield and embryo quality in a large donor cohort. Methods: We retrospectively analyzed 584 donor IVF cycles at a single center (Jan 1, 2018-Dec 31, 2023). Donor variables included age, AMH, BMI (body mass index), and baseline hormones. Stimulation used gonadotropin-releasing hormone (GnRH) antagonist (27.1%) or progestin-primed ovarian stimulation (PPOS)(72.9%); recombinant human luteinizing hormone (LH) was used in 86% of cycles; final maturation was GnRH agonist (GnRHa) (59.4%) or dual trigger (40.6%). Outcomes were oocyte yield and embryo quality metrics (maturation, two-pronuclear (2PN) fertilization, Day 3 good-quality embryo rate, blastocyst formation rate, and top-quality blastocyst rate). Multivariable linear regression and propensity score matching (PSM) compared protocols and LH supplementation. Results: Donors were 25.6 ± 3.7 years with AMH 6.1 ± 2.9 ng/mL and BMI 21.6 ± 2.8 kg/m². Per cycle: 27.1 ± 11.1 oocytes, 20.8 ± 8.3 MII (maturation 78.2 ± 13.4%), 2PN fertilization 73 ± 18%, Day 3 good-quality embryos 10.6 ± 6.0 (69.5 ± 23.5%), blastocysts 9.5 ± 5.5 (56.7 ± 22.5%), and top-quality blastocysts 6.1 ± 4.2 (36.5 ± 20.1%). First transfers (n=491) yielded 55.4% clinical pregnancy and 44.4% live birth; miscarriage 12.2%. AMH independently predicted oocyte number; higher BMI was associated with lower fertilization. PPOS produced lower Day 3 good-quality embryo (67.9% vs 72.8%) and top-quality blastocyst rates (59.7% vs 74.1%) versus antagonist in PSM, with similar blastocyst formation rate (64.0% vs 60.9%). LH supplementation modestly increased fertilization (74.4% vs 69.5%) without downstream differences. Dual trigger was associated with reduced blastocyst formation rate but a higher proportion of top-quality blastocysts. Conclusions: In donor IVF, AMH is the principal predictor of oocyte yield, whereas BMI, stimulation protocol, and trigger method influence embryo quality. Despite protocol-dependent morphology differences, pregnancy and live birth rates remained high. Findings support individualized stimulation strategies that consider donor profile and protocol effects to optimize efficiency and outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.